The first clues about the molecular basis of melanoma came from studies of families prone to the disease and the identification of two autosomal-dominant high-susceptibility loci: cyclin-dependent kinase inhibitor 2A (CDKN2A) and cyclin-dependent kinase 4 (CDK4). The gene discussed is CDKN2A; the disease is melanoma.